Skip to search formSkip to main contentSkip to account menu

Transformed Recurrent Non-Hodgkin Lymphoma

Known as: Transformed Recurrent Non-Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Transformed Recurrent, Transformed Lymphoma 
The reemergence of non-Hodgkin lymphoma transformed after a period of remission.
National Institutes of Health

Related topics

Related topics

12 relations
Atypical lymphocyteHematopoietic and Lymphoid CellHematopoietic and Lymphoid TissueLymphatic System

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL.
Ibrutinib has generated remarkable responses in patients with chronic lymphocytic leukemia (CLL), including those with an… 
2016
2016
Weakly-bound three-body nuclear systems: structure, reactions and astrophysical implications
Esta memoria de tesis surge con la idea de estudiar sistemas nucleares de interes astrofisico.La comprension de los procesos de… 
2014
2014
Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy
The optimum follow-up of patients with transformed indolent lymphoma (TrIL) is not well defined. We sought to determine the… 
2013
2013
Continuum-Discretized Coupled-Channels calculations with core excitation
The effect of core excitation in the elastic scattering and breakup of a two-body halo nucleus on a stable target nucleus is… 
Highly Cited
2011
Highly Cited
2011
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.
BACKGROUND Lenalidomide is an immunomodulatory agent with antitumor activity in B-cell malignancies. This phase II trial aimed to… 
2008
2008
Salvage Therapy with Allogeneic Stem Cell Transplantation Results in Better Outcome for Patients with Relapsed/Refractory Follicular Lymphoma Compared to Those with Transformed Non-Hodgkin Lymphoma…
We compared the outcome of patients who received myeloablative allogeneic stem cell transplantation for relapsed follicular and… 
2003
2003
Establishment and Characterization by Gene Expression Profiling of a New Diffuse Large B-Cell Lymphoma Cell Line, EJ-1, Carrying t(14;18) and t(8;14) Translocations
Establishment and Characterization by Gene Expression Profiling of a New Diffuse Large B-Cell Lymphoma Cell Line, EJ-1, Carrying… 
Review
2002
Review
2002
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue
Abstract. Treatment of aggressive lymphoma in relapse is difficult. Patients who initially present with these diseases often know… 
Highly Cited
2001
Highly Cited
2001
Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma.
A synergistic interaction of Bcl-2 and c-Myc plays a role in lymphomagenesis in mice and in some patients as well. Progression of… 
1980
1980
Selection for virulence and organ‐specific metastasis of herpesvirus‐transformed lymphoma cells
The Marek's Disease virus‐transformed, non‐producer, lymphoma cell line, MDCC‐RP1, was selected by sequential transplantation to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)